Site Search

Connecting Patients with the Right Treatment at the Right Time Treatment with targeted therapy often requires diagnostic testing to analyze biological samples (e.g., blood, tumor tissue) taken from a patient to identify and evaluate specific biomarkers. Research shows ... treatment for their cancer, patients can avoid treatments that will be ineffective or have more adverse side effects. Insurance coverage for biomarker testing is failing to keep pace with innovations and advancements in treatment. We must work to dismantle barriers that prevent all patients from benefiting from biomarker testing and precision medicine.    Expanding Access to Patient Navigation  Navigating the healthcare system can be confusing and ...

... access to care, we can reduce suffering and death from this disease.” Specifically, the Illinois volunteers asked the legislature to: Support Biomarker Testing Legislation : support legislation that will expand coverage of biomarker testing – an essential step in accessing precision medicine treatments. Dubbed ‘the right treatment, to the right patient, at the ...

... Here are the bill names, current bill numbers, and lead legislative sponsors for each of our bills: An Act relative to cancer patient access to biomarker testing - SD 1687 - Sen. Susan Moran & HD 2413 - Rep. Meghan Kilcoyne An Act empowering health care consumers - SD 625 - Sen. Brendan Crighton & ...

... by taking steps to make the fight against cancer a priority.”  Advocates asked lawmakers to support legislation that would improve access to biomarker testing. Dubbed ‘the right treatment at the right time,’ biomarker testing has been critical in improving cancer outcomes. Advocates also asked lawmakers to provide better access to care by passing co-pay ...